Summary

Novavax, Inc. - Company Profile and SWOT Analysis

Summary

Novavax, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Novavax, Inc. (Novavax) discovers, develops and markets vaccines for the prevention of serious infectious diseases. The company's major offerings include various vaccine candidates against respiratory syncytial virus (RSV), seasonal influenza, R21 and the Ebola virus. Novavax markets vaccine candidates under Novavax, ResVax, Resolve, Prepare, Matrix, and Nuvaxovid brand names. It uses innovative proprietary recombinant nanoparticle vaccine technologies to develop various vaccines related to emerging disease threats. The company also develops various adjuvant formulations through Matrix-M technology. Novavax operates research and manufacturing facilities in the US, Sweden, and Czech Republic. The company is headquartered in Gaithersburg, Maryland, the US.

Scope

- Detailed information on Novavax, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novavax, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Novavax, Inc. including a breakdown and examination of key business segments
- Intelligence on Novavax, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novavax, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Novavax, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novavax, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novavax, Inc.'s business structure, strategy and prospects.

ページTOPに戻る

Table of Contents

Table of Contents
Company Snapshot
Novavax, Inc.: Company Overview
Novavax, Inc.: Overview and Key Facts
Novavax, Inc.: Overview
Novavax, Inc.: Key Facts
Novavax, Inc.: Key Employees
Novavax, Inc.: Key Employee Biographies
Novavax, Inc.: Major Products and Services
Novavax, Inc.: Management Statement
Novavax, Inc.: Locations and Subsidiaries
Novavax, Inc.: Key Competitors
Novavax, Inc.: Company Analysis
Novavax, Inc.: Business Description
Novavax, Inc.: SWOT Analysis
Novavax, Inc.: SWOT Overview
Novavax, Inc.: Strengths
Novavax, Inc.: Weaknesses
Novavax, Inc.: Opportunities
Novavax, Inc.: Threats
Novavax, Inc.: Corporate Financial Deals Activity
Novavax, Inc.: Financial Deals Overview
Novavax, Inc.: Targets and Partners
Novavax, Inc.: Top Deals 2022 - 2026YTD*
Novavax, Inc.: Advisors
Novavax, Inc.: Top Legal Advisors
Novavax, Inc.: Top Financial Advisors
Novavax, Inc.: Capital Raising
Novavax, Inc.: Partnership
Novavax, Inc.: Divestments
Novavax, Inc.: Private Equity and Ownership
Novavax, Inc.: Recent Developments
Novavax, Inc.: News and Events Summary
Novavax, Inc.: Contracts
Novavax, Inc.: Corporate Governance
Novavax, Inc.: Market Developments
Novavax, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1: Novavax, Inc.: Key Facts
Table 2: Novavax, Inc.: Key Employees
Table 3: Novavax, Inc.: Locations and Subsidiaries
Table 4: Novavax, Inc.: Key Competitors
Table 5: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Novavax, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Table 7: Novavax, Inc.: Targets and Partners
Table 8: Novavax, Inc.: Top Deals 2022 - 2026YTD*
Table 9: Novavax, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Novavax, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Novavax, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026)
Table 12: Novavax, Inc.: Capital Raising by Deal Type (2022 - YTD*2026)
Table 13: Novavax, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Table 14: Novavax, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Table 15: Novavax, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
Table 16: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2022 - YTD*2026)
Table 17: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2022 - YTD*2026)
Table 18: Novavax, Inc.: News and Events Summary
Table 19: Novavax, Inc.: Contracts
Table 20: Novavax, Inc.: Corporate Governance
Table 21: Novavax, Inc.: Market Developments
Table 22: Novavax, Inc.: Research & Development
List of Figures
Figure 1: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Novavax, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Figure 3: Novavax, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026)
Figure 4: Novavax, Inc.: Capital Raising by Deal Type (2022 - YTD*2026)
Figure 5: Novavax, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Figure 6: Novavax, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Figure 7: Novavax, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
Figure 8: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2022 - YTD*2026)
Figure 9: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2022 - YTD*2026)